Advent Capital Management HALOZYME THERAPEUTICS IN Transaction History

Advent Capital Management

  • $195 Million
  • Q2 2025
Number of Shares
8,764,000
Previous 11,220,000 21.89%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
N/A
-2,456,000 Reduced 21.89%
8,764,000 $0
Q1 2025

May 12, 2025
SELL
N/A
-30,011,000 Reduced 72.79%
11,220,000 $0
Q4 2024

Feb 13, 2025
BUY
N/A
41,116,000 Added 35753.04%
41,231,000 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-22,918,000 Reduced 99.5%
115,000 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-26,894,000 Reduced 53.87%
23,033,000 $0
Q1 2024

May 14, 2024
SELL
N/A
-6,066,000 Reduced 10.83%
49,927,000 $0
Q4 2023

Feb 13, 2024
SELL
N/A
-18,360,000 Reduced 24.69%
55,993,000 $0
Q3 2023

Nov 13, 2023
BUY
N/A
74,353,000 New
74,353,000 $0
Track This Portfolio

Track Advent Capital Management Portfolio

Follow Advent Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

News

Stay updated on Advent Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email